According to Google DeepMind, the AlphaGenome API is now processing over 1 million API calls daily from more than 3000 users across 160 countries. Researchers are leveraging this advanced model to address complex challenges in biology, highlighting its global reach and significant adoption in scientific research. As reported by Google DeepMind, the model's practical applications span genomics, drug discovery, and protein analysis, demonstrating tangible business opportunities for biotechnology and pharmaceutical companies seeking AI-powered solutions.